Results from Recent Clinical Trials to be presented at the American Society of Hematology Conference in December 2017
Posted on
New Phase 1/2 Study Data for ALXN1210 as a Potential Future Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) to Be Presented at American Society of Hematology (ASH) Meeting Data […]
Read more About Results from Recent Clinical Trials to be presented at the American Society of Hematology Conference in December 2017